Effects of angiotensin-converting enzyme inhibitors on the treatment of anemia with erythropoietin

被引:38
作者
Hayashi, K [1 ]
Hasegawa, K [1 ]
Kobayashi, S [1 ]
机构
[1] Kirin Brewery Co Ltd, Div Pharmaceut, Shibuya Ku, Tokyo, Japan
关键词
hemodialysis; hematocrit; hypertension; blood pressure; erythropoiesis; quality of life; kidney; renal anemia;
D O I
10.1046/j.1523-1755.2001.00028.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. The hypothesis that angiotensin-converting enzyme (ACE) inhibitors interfere with the treatment of anemia with recombinant human erythropoietin (rHuEPO) remains controversial. To test this hypothesis, a retrospective analysis was conducted in a large group of hemodialysis patients with renal anemia. Methods. The effects of ACE inhibitors in these patients were evaluated by measuring the weekly increment in hematocrit (Delta Hct) values within 12 weeks of the initiation of rHuEPO treatment. Results from 2213 rHuEPO naive patients were compared between patients receiving rHuEPO alone and patients receiving both rHuEPO and ACE inhibitors. Because of the demographic differences between the two groups, a propensity score was used to eliminate the influence of confounding factors and to match the patient population in these two patient groups. Multiple regression analysis also was performed. Results. When the Delta Hct values were compared directly between the two groups or were assessed by multiple regression analysis, no effect of ACE inhibitors was observed (P = 0.941 and P = 0.308, respectively). When the effects of ACE inhibitors on the treatment of anemia with rHuEPO were analyzed in 329 patients extracted from each group by their propensity score, Delta Hct did not differ between the two groups (P = 0.355). Conclusions. These results suggest that ACE inhibitors have no effect on the rHuEPO treatment for anemia in hemodialysis patients who were treated with a relatively low dose of ACE inhibitors and low-dose rHuEPO.
引用
收藏
页码:1910 / 1916
页数:7
相关论文
共 25 条
[1]   ACE inhibitors do not induce recombinant human erythropoietin resistance in hemodialysis patients [J].
Abu-Alfa, AK ;
Cruz, D ;
Perazella, MA ;
Mahnensmith, RL ;
Simon, D ;
Bia, MJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (06) :1076-1082
[2]   High dose enalapril impairs the response to erythropoietin treatment in haemodialysis patients [J].
Albitar, S ;
Genin, R ;
Fen-Chong, M ;
Serveaux, MO ;
Bourgeon, B .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (05) :1206-1210
[3]  
[Anonymous], 1997, Am J Kidney Dis, V30, pS192
[4]   Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline [J].
Azizi, M ;
Rousseau, A ;
Ezan, E ;
Guyene, TT ;
Michelet, S ;
Grognet, JM ;
Lenfant, M ;
Corvol, P ;
Menard, J .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (03) :839-844
[5]   Effect of angiotensin-converting enzyme inhibitors on response to erythropoietin therapy in chronic dialysis patients [J].
Charytan, C ;
Goldfarb-Rumyantzev, A ;
Wang, YF ;
Schwenk, MH ;
Spinowitz, BS .
AMERICAN JOURNAL OF NEPHROLOGY, 1998, 18 (06) :498-503
[6]   Lack of angiotensin II-facilitated erythropoiesis causes anemia in angiotensin-converting enzyme-deficient mice [J].
Cole, J ;
Ertoy, D ;
Lin, HC ;
Sutliff, RL ;
Ezan, E ;
Guyene, TT ;
Capecchi, M ;
Corvol, P ;
Bernstein, KE .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (11) :1391-1398
[7]   Effects of the angiotensin-converting enzyme inhibitor enalapril on blood haematopoietic progenitors and Acetyl-N-Ser-Asp-Lys-Pro concentrations [J].
Comte, L ;
Lorgeot, V ;
Volkov, L ;
Allegraud, A ;
Aldigier, JC ;
Praloran, V .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1997, 27 (09) :788-790
[8]   Angiotensin-converting enzyme inhibitor therapy in chronic hemodialysis patients: Any evidence of erythropoietin resistance? [J].
Cruz, DN ;
Perazella, MA ;
AbuAlfa, AK ;
Mahnensmith, RL .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (04) :535-540
[9]  
D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO
[10]  
2-B